Last Updated on June 22, 2023

Forum on Immunopathological Diseases and Therapeutics- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Begell House Inc.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.11

SJR

 0.107

h-Index

 14

Rank

 25656

Important Details

Title Forum on Immunopathological Diseases and Therapeutics
Type of Publication Journal
Discipline Biochemistry (Q4); Biotechnology (Q4); Genetics (Q4); Molecular Medicine (Q4)
Impact Score 0.11
SCImago Journal Rank (SJR) 0.107
h-index 14
Overall Rank 25656
Publisher Name Begell House Inc.
Publication Country United States
International Standard Serial Number (ISSN) 21518025, 21518017
Coverage and History 2010-2016, 2021
Best Quartile Q4
Total Citations Received
(Last 3 Year)
1

About Forum on Immunopathological Diseases and Therapeutics


Forum on Immunopathological Diseases and Therapeutics is a journal published by Begell House Inc.. This journal covers the area[s] related to Biochemistry, Biotechnology, Genetics, Molecular Medicine, etc. The coverage history of this journal is as follows: 2010-2016, 2021. The rank of this journal is 25656. This journal's impact score, h-index, and SJR are 0.11, 14, and 0.107, respectively. The ISSN of this journal is/are as follows: 21518025, 21518017.

The best quartile of Forum on Immunopathological Diseases and Therapeutics is Q4. This journal has received a total of 1 citations during the last three years (Preceding 2022).


Forum on Immunopathological Diseases and Therapeutics Impact Score 2022-2023


The latest impact score (IS) of the Forum on Immunopathological Diseases and Therapeutics is 0.11. It is computed in the year 2023 as per its definition and based on Scopus data.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Forum on Immunopathological Diseases and Therapeutics Impact Score 2023


Impact Score 2022 of Forum on Immunopathological Diseases and Therapeutics is 0.11. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Forum on Immunopathological Diseases and Therapeutics. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.11
2021 0.00
2019 0.00
2018 0.61
2017 0.13
2016 0.08
2015 0.15
2014 0.48

Forum on Immunopathological Diseases and Therapeutics h-index


  Table Setting

The h-index of Forum on Immunopathological Diseases and Therapeutics is 14. By definition of the h-index, this journal has at least 14 published articles with more than 14 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Forum on Immunopathological Diseases and Therapeutics ISSN


The International Standard Serial Number (ISSN) of Forum on Immunopathological Diseases and Therapeutics is/are as follows: 21518025, 21518017.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Forum on Immunopathological Diseases and Therapeutics Ranking and SCImago Journal Rank (SJR)


The Forum on Immunopathological Diseases and Therapeutics is ranked 25656 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.107.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Forum on Immunopathological Diseases and Therapeutics Publisher


Table Setting

The publisher of Forum on Immunopathological Diseases and Therapeutics is Begell House Inc.. The publishing house of this journal is located in the United States. Its coverage history is as follows: 2010-2016, 2021.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


How to publish in Forum on Immunopathological Diseases and Therapeutics


If your area of research or discipline is related to Biochemistry, Biotechnology, Genetics, Molecular Medicine, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Forum on Immunopathological Diseases and Therapeutics?

The latest impact score of Forum on Immunopathological Diseases and Therapeutics is 0.11. It is computed in the year 2023.


What is the h-index of Forum on Immunopathological Diseases and Therapeutics?

The latest h-index of Forum on Immunopathological Diseases and Therapeutics is 14. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Forum on Immunopathological Diseases and Therapeutics?

The latest SCImago Journal Rank (SJR) of Forum on Immunopathological Diseases and Therapeutics is 0.107. It is calculated in the year 2023.


What is the ranking of Forum on Immunopathological Diseases and Therapeutics?

The latest ranking of Forum on Immunopathological Diseases and Therapeutics is 25656. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Forum on Immunopathological Diseases and Therapeutics?

Forum on Immunopathological Diseases and Therapeutics is published by Begell House Inc.. The publication country of this journal is United States.


What is the abbreviation of Forum on Immunopathological Diseases and Therapeutics?

This standard abbreviation of Forum on Immunopathological Diseases and Therapeutics is .


Is "Forum on Immunopathological Diseases and Therapeutics" a Journal, Conference or Book Series?

Forum on Immunopathological Diseases and Therapeutics is a journal published by Begell House Inc..


What is the scope of Forum on Immunopathological Diseases and Therapeutics?

The scope of Forum on Immunopathological Diseases and Therapeutics is as follows:

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Medicine

For detailed scope of Forum on Immunopathological Diseases and Therapeutics, check the official website of this journal.


What is the ISSN of Forum on Immunopathological Diseases and Therapeutics?

The International Standard Serial Number (ISSN) of Forum on Immunopathological Diseases and Therapeutics is/are as follows: 21518025, 21518017.


What is the best quartile for Forum on Immunopathological Diseases and Therapeutics?

The best quartile for Forum on Immunopathological Diseases and Therapeutics is Q4.


What is the coverage history of Forum on Immunopathological Diseases and Therapeutics?

The coverage history of Forum on Immunopathological Diseases and Therapeutics is as follows 2010-2016, 2021.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Historia Journal Universidade Estadual Paulista 27560 7 0.02
Proceedings of the International Symposium on Power Semiconductor Devices and ICs Conference And Proceedings 7015 49 2.14
Business Strategy Review Journal Wiley-Blackwell Publishing Ltd 31512 33 0.04
World Englishes Journal Wiley-Blackwell 4960 60 1.97
Journal of Education and Work Journal Brill Academic Publishers 9268 43 1.93
International Journal of Research and Method in Education Journal Taylor and Francis Ltd. 5180 34 2.49
Canadian Journal of Mathematics Journal Canadian Mathematical Society 3905 43 0.79
International Journal of Pest Management Journal Taylor and Francis Ltd. 13393 50 1.50
Rudarsko Geolosko Naftni Zbornik Journal University of Zagreb, Faculty of Mining, Geology and Petroleum Engineering 14294 17 1.48
Clinical Interventions in Aging Journal Dove Medical Press Ltd. 4777 96 3.57

Check complete list




Forum on Immunopathological Diseases and Therapeutics Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 0.11
2021 0.00
2019 0.00
2018 0.61
2017 0.13
2016 0.08
2015 0.15
2014 0.48



Top Journals/Conferences in Biochemistry

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Nature Catalysis
Nature Publishing Group | United States

Annual Review of Biochemistry
Annual Reviews Inc. | United States

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

Annual Review of Biophysics
Annual Reviews Inc. | United States

Chem
Elsevier Inc. | United States

Nature Protocols
Nature Publishing Group | United Kingdom

Annals of the Rheumatic Diseases
BMJ Publishing Group | United Kingdom

Molecular Systems Biology
Wiley-Blackwell | United States

Journal of the American Chemical Society
American Chemical Society | United States

Cell Reports Medicine
Cell Press | United States

EMBO Journal
Wiley-Blackwell | Germany

See All

Top Journals/Conferences in Biotechnology

Nature Biotechnology
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Nature Microbiology
Nature Publishing Group | United Kingdom

Nature Biomedical Engineering
Nature Publishing Group | United States

PLoS Medicine
Public Library of Science | United States

Nano Today
Elsevier | Netherlands

Annual Review of Animal Biosciences
Annual Reviews Inc. | United States

Small
Wiley-VCH Verlag | Germany

Protein and Cell
Higher Education Press | China

Biofuel Research Journal
Green Wave Publishing of Canada | Canada

Green Synthesis and Catalysis
KeAi Communications Co. | China

Ageing Research Reviews
Elsevier Ireland Ltd | Ireland

Plant Communications
Cell Press | United States

Plant Biotechnology Journal
Wiley-Blackwell Publishing Ltd | United Kingdom

Bioactive Materials
KeAi Communications Co. | Netherlands

See All

Top Journals/Conferences in Genetics

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Nature Genetics
Nature Publishing Group | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United States

Genome Biology
BioMed Central Ltd. | United Kingdom

Nature Microbiology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Nucleic Acids Research
Oxford University Press | United Kingdom

Annual Review of Genetics
Annual Reviews Inc. | United States

Nature Protocols
Nature Publishing Group | United Kingdom

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Annals of the Rheumatic Diseases
BMJ Publishing Group | United Kingdom

Molecular Systems Biology
Wiley-Blackwell | United States

Cell Reports Medicine
Cell Press | United States

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

See All